Bristol-Myers Squibb (DE:BRM)
XETRA:BRM
Holding DE:BRM?
Track your performance easily

Bristol-Myers Squibb (BRM) Financial Statements

16 Followers

Bristol-Myers Squibb Financial Overview

Bristol-Myers Squibb's market cap is currently ―. The company's EPS TTM is €; its P/E ratio is ―; and it has a dividend yield of 4.39%. Bristol-Myers Squibb is scheduled to report earnings on February 6, 2025, and the estimated EPS forecast is €1.36. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Jun 24Mar 24Dec 23Sep 23
Income Statement-
Total Revenue$ 11.89B$ 12.20B$ 11.87B$ 11.48B$ 10.97B
Gross Profit$ 8.94B$ 8.93B$ 8.93B$ 8.73B$ 8.46B
EBIT$ 2.18B$ 1.28B$ -11.09B$ 1.99B$ 2.13B
EBITDA$ 4.77B$ 3.88B$ -8.56B$ 4.45B$ 4.57B
Net Income Common Stockholders$ 1.21B$ 1.68B$ -11.91B$ 1.76B$ 1.93B
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 8.09B$ 6.65B$ 9.67B$ 12.28B$ 8.01B
Total Assets$ 93.67B$ 94.65B$ 99.03B$ 95.16B$ 91.26B
Total Debt$ 49.75B$ 52.39B$ 55.68B$ 39.77B$ 37.60B
Net Debt$ 41.66B$ 45.74B$ 46.01B$ 27.49B$ 29.59B
Total Liabilities$ 76.47B$ 77.58B$ 82.48B$ 65.67B$ 62.20B
Stockholders Equity$ 17.14B$ 17.02B$ 16.49B$ 29.43B$ 29.00B
Cash Flow-
Free Cash Flow$ 5.27B$ 2.06B$ 2.55B$ 3.92B$ 4.41B
Operating Cash Flow$ 5.59B$ 2.33B$ 2.83B$ 4.25B$ 4.75B
Investing Cash Flow$ -219.00M$ -1.32B$ -19.62B$ -1.35B$ -410.00M
Financing Cash Flow$ -3.85B$ -4.02B$ 14.64B$ 967.00M$ -5.16B
Currency in USD

Bristol-Myers Squibb Earnings and Revenue History

Bristol-Myers Squibb Debt to Assets

Bristol-Myers Squibb Cash Flow

Bristol-Myers Squibb Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis